
Uncovering Fraud in Pharmaceutical R&D and Manufacturing. By popular demand, I will include my art pieces that have nothing to do with Pharma. If you are interested in my art, visit www.sashalatypova.com
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 682 | Founded | 4 years ago | Last Issue | 6 days ago |
| Active | |||||

When confronted with facts about vaccine harms, pro-vaccination fanatics immediately invoke the sacred cow: “but polio!” and claim that this dangerous epidemic virus was eradicated by lifesaving vaccines. This claim is categorically not tru...
In this post I am providing excerpts from the essay: “Cancer and Cronyism at the NIH: Norton Zinder and the Special Virus Cancer Program” by Antoinette Sutto, Robert D. L. Gardiner Historian (Cold Spring Harbor Laboratory). It covers the Zi...
This post is a compilation of recent news in the field of Public Hellth before we take a short break to attend the [cheerful] memorial services for what 250 years ago was a reasonably good idea of an independent country, with Constitutional...
This article was originally published on January 1, 2024.
I am republishing it now, because yesterday I have received AI-written death threats from some low IQ incel(s) going by name “Skytoshi” on Substack. I have had numerous very aggres...
This post is a republish of an article that I wrote in 2025, when this “DNA rejuvenation elixir” cooked up in Harvard was greenlit by MAHA-FDA for first in human trials. I am republishing it, because in a rather shocking turn of events, the...
Subscribers, engagement, traffic and sponsorship for Due Diligence and Art.
| Subscribers | Engagement | 91 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where Due Diligence and Art ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 88 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #19 | |
| #17 |
The writers behind this newsletter.
I could not become a professional artist, so I became a pharma and medical device R&D executive. If you are interested in my art, visit sashalatypova.com
I could not become a professional artist, so I became a pharma and medical device R&D executive. If you are interested in my art, visit sashalatypova.com
You can find recent issues that have been published by Due Diligence and Art on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Due Diligence and Art, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Due Diligence and Art as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Due Diligence and Art using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Due Diligence and Art. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.